Albany, NY -- (SBWIRE) -- 04/27/2016 -- The Lyme disease, if not diagnosed and treated on time, can be a cause of death. Thousands of people worldwide are affected by the disease every year. This has created a sizeable market for lyme disease diagnostic and treatment. Transparency Market Research studies the future of this market in its new report, titled, 'Lyme Disease Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019.' The report states that the demand diagnosing and treating lyme disease is expected to rise in the coming years as the incidence of the disease is showing a gradual rise.

It is the most common tickborne diseases in the United States, where there is a high demand for effective treatment for the same. The United States has helped place the North America region in a dominant position in the global lyme disease diagnostic market.

Lyme diseases, which manifests itself in the form of symptoms such as a characteristic skin rash, fever, fatigue, and headache, is caused by a bacterium called Borrelia burgdorferi. The disease is transmitted via blacklegged ticks that are infected by the bacterium. The timely diagnosis and treatment of the infection is imperative as it could otherwise spread to the heart, joints, and nervous system. This has stirred up a massive demand for lyme disease diagnostics so that a proper course of treatment can be recommended by physicians to people suffering from the disease. Typically, a laboratory test may be conducted to ascertain the presence of lyme disease. Such a diagnostic procedure has proven efficient if performed using validated methods. If the diagnosis is positive, the physician may prescribe antibiotics to the patient for a few weeks.

Currently, the best way to prevent lyme disease is to use an effective insect repellant, by promptly removing ticks, and using pesticides to reduce tick habitats. It is important to note that ticks carrying the lyme disease are also carriers of other tickborne infections and diseases.

The report segments the global lyme disease diagnostic market based on diagnostic tests, end users, and emerging diagnostic technologies. The key emerging technologies studied in the report include: molecular diagnostics, immunoassays, monoclonal antibodies, liposomes, differential light scattering, flow cytometry, artificial intelligence, diagnostic imaging, information technology, chromatography, and gel microdroplets.

Likewise, the report studies the leading end users in the global lyme disease diagnostic market. These include: commercial/private labs, hospitals, physicians office, and public health labs.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1658

Serological tests are among the most widely used laboratory tests to determine whether a person has been affected by the lyme disease. Western Blot and ELISA are the two most commonly used tests in the market. However, serology tests have the disadvantage of not being always accurate. Other common test types that contribute appreciable revenue to the lyme disease diagnostic market are PCR tests, urine antigen tests, immunofluorescent staining, and lymphocytic transformation test.

Companies that are currently at the forefront of the global lyme disease diagnostic market include: Affymetrix, Inc., Abbott Laboratories, and Bio-Rad, Roche Diagnostics.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/